Member Info for a4007035

What is everyone's SXX SP targets before they consider selling? I invested several years ago and then stayed away from any news with hopes to re-visit the investment in 2021. But recent news has made me re-visit a lot sooner than expected.

Does anyone know when the acquisition will actually go through?

Hi

This is the first time I have been in this situation and I was hoping someone could clarify a few things for me:
Does this mean that my Scisys holding will be sold
Is it sold automatically
Is there anything I need to do

The investment strategy here is simple: Long and Hold. CLIN has made a number of acquisitions over the last 3 years. These are yet to be fully consolidated and integrated within the Group.

Such a well run company. They seem to have got the perfect balance between risk and reward. I really have faith in the management team here.

Give it 5 years.

It will definitely been a good report.

You only have to look at the order updates throughout the year to know that. My only worry is that under IFRS15 the results may look unfavourable. But like for like compared to last year, this set of results will be positive.

LONDON (Alliance News) - Data solutions provider D4T4 Solutions PLC on Tuesday said it has won and extended a number of significant global contracts.

The company said it signed a multi-year data management contract with an unnamed global US head-quartered financial institution for its private cloud data analytics platform solution.

Furthermore, in data collection, D4T4 inked a multi-year contract extension for its Celebrus mobile data collection software with a "major" European bank, as well as a multi-year capacity expansion contract with a "major" global airline.

It also secured new multi-year contracts for Celebrus with two Scandinavian financial services customers.

"We are delighted with this wave of contract successes which, coming at the close of the financial period, provide valuable underpinning to our future earnings and are testimony to the momentum we have built in the business," Chief Executive Officer Pete Kear said.

Over time SXX will be a better bet. However, SXX SP won't increase until financing arrangements have been agreed. So you could have maybe held CLIN for a bit longer. You still have 2/3 of your holding though. I reckon CLIN can get in the high 20s in the next few years. SXX could be pushing the hundreds.

Until Bango turns into a cash generative company I am yet to be convinced. And I think the market shares the same opinion too.

Your assumptions that doubling the EUS will simply add £5m of cash. However, there are associated costs and overheads that need to be considered.

At the end of the day cash is burning a hole in the pockets and the cashflow statement does not lie. They barely have enough money to pay the current liabilities which will be due in the next 12 months. Even if EUS was to double the margins are poor that it would see little profit (if any).

Made me laugh seeing a strong buy opinion yesterday.

TALK is simply undervalued. Expect it to be 150 when results are announced.

Link is here http://otp.investis.com/clients/uk/swallowfield_plc/rns/regulatory-story.aspx?cid=1483&newsid=1237605

Pretty bad on the face of it:
Operating profit and EPS halved from 2018

The key of SWL is whether they can go grow the brands market internationally. UK Retail is dead in the water and Brexit is not going to help. SWL need to branch out but in such a competitive market brand and reputation are so important. I'm not too sure how well the SWL brand is recognised internationally. Only time will tell.

You always get the feeling with Tlou that the Botswana tender will be make or break for the company. There doesn't really seem to be a Plan B. Should they not be awarded the tender the SP will plummet. I have a speculative investment here (call it a gamble if you like) but I am not too hopeful in the final outcome. You only have to look at the SP trend since Jan 2018.

Not 100% sure. I thought that 800 would be the bottom line but SP has obviously continued negatively towards that. The good thing is that its not the company's fault of the downwards trend. Fundamentals still remain the same. But market factors particularly in the regions where CLIN operates means that there is a degree of uncertainty which seems to be spooking investors. We can only hope for more stability within the political landscape.

I topped up just above 800. But I feel it would be irresponsible of me to tell anyone to top up at this price. My strategy remains the same for CLIN: Long and hold.

Fundamentals still look strong for BGO. It's not a traders stock. It's a long and hold stock. The way end user spend is increasing means there is no point selling now. No point checking the SP until 2020 really to see how EUS has developed and to see whether there are any signs of it slowing down.

Apparently there are rumours circulating that Petro Matad have located Crisp n Dry Oil in a nearby Netto. Awaiting confirmation.

Hi All,

Just wanted to reassure investors that the change of auditor to EY has no cause for concern. Having worked in the audit industry i understand that its due to the quality of the KPMG Audit Team.

Do we have another Unilever situation on our hands?

This is a great opportunity to top up / entry price for new investors. This will slowly get back to £10 per share. The decrease will be predominately exchange rate.